ClinicalTrials.Veeva

Menu

Physical Activity Measured Through Accelerometers and Its Association With Endothelial Function in Young Patients With Fontan Physiology

U

University of Alberta

Status

Completed

Conditions

Heart Defects

Treatments

Other: Physical activity measures via Actigraph GT3X+ accelerometers for 7 consecutive days

Study type

Interventional

Funder types

Other

Identifiers

NCT02938429
Pro00060485

Details and patient eligibility

About

This study will be a cross sectional assessment of physical activity as measured through accelerometers and its association with endothelial function of children with Fontan circulation and healthy age and gender matched controls who are followed at the University of Alberta - Stollery Children's hospital.

Enrollment

25 patients

Sex

All

Ages

24 months to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Children with Fontan physiology between the ages 24 months to 18 years at the Stollery Children's Hospital
  2. Informed written consent obtained prior to enrolment
  3. At least 6 months post Fontan procedure

Exclusion criteria

  1. Patient hospitalized within the previous 2 weeks
  2. Patient unable to ambulate independently
  3. Underwent coarctation of the aorta repair using a subclavian flap.

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 2 patient groups

Participants with Fontan circulation
Other group
Description:
Physical activity measurements: Participants will wear Actigraph GT3X+ accelerometers for 7 consecutive days and complete a physical activity log. Data from the accelerometers and physical activity log will be cross referenced. Endothelial function measurements: Participants undergo Digital Thermal Monitoring (DTM) via Vendys (VENDYS-6000, Endothelix Inc., Houston, TX). Since DTM is not currently a validated tool and its use has not been published in a paediatric population, we will employ a second assessment of endothelial function, the Endothelial Pulse Amplitude Test (Endo-PAT, Itamar Medical). Participants will complete a questionnaire to access factors that can affect endothelial function.
Treatment:
Other: Physical activity measures via Actigraph GT3X+ accelerometers for 7 consecutive days
Age and gender matched controlled
Other group
Description:
Physical activity measurements: Participants will wear Actigraph GT3X+ accelerometers for 7 consecutive days and complete a physical activity log. Data from the accelerometers and physical activity log will be cross referenced. Endothelial function measurements: Participants undergo Digital Thermal Monitoring (DTM) via Vendys (VENDYS-6000, Endothelix Inc., Houston, TX). Since DTM is not currently a validated tool and its use has not been published in a paediatric population, we will employ a second assessment of endothelial function, the Endothelial Pulse Amplitude Test (Endo-PAT, Itamar Medical). Participants will complete a questionnaire to access factors that can affect endothelial function.
Treatment:
Other: Physical activity measures via Actigraph GT3X+ accelerometers for 7 consecutive days

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems